INmune Bio Inc.
INMB
$2.17
$0.094.33%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -44.83% | 10.45% | 18.30% | -17.34% | 7.42% |
| Total Receivables | 121.21% | -45.62% | 222.29% | 73.52% | -36.86% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 22.97% | 235.27% | 79.76% | -46.30% | -50.15% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -33.95% | 8.88% | 31.88% | -14.45% | 1.52% |
|
|
|||||
| Total Current Assets | -33.95% | 8.88% | 31.88% | -14.45% | 1.52% |
| Net Property, Plant & Equipment | 132.31% | 732.01% | 508.79% | 479.70% | 197.52% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -5.79% | 1,293.88% | 653.16% | 809.76% | 603.70% |
| Total Assets | -28.76% | -31.70% | -18.23% | -36.80% | -28.16% |
|
|
|||||
| Total Accounts Payable | -34.13% | -35.27% | 18.79% | -35.08% | -17.36% |
| Total Accrued Expenses | -86.41% | -- | 0.00% | -54.55% | 32.37% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 269.09% | 382.19% | 345.00% | -82.62% | -95.69% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -1.92% |
| Total Other Current Liabilities | -- | -- | -- | -- | -1.92% |
| Total Current Liabilities | -31.40% | -32.03% | 16.55% | -46.78% | -42.95% |
|
|
|||||
| Total Current Liabilities | -31.40% | -32.03% | 16.55% | -46.78% | -42.95% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 156.71% | 301.00% | 68.44% | 119.37% | -28.26% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -26.47% | -23.79% | 18.25% | -43.43% | -42.65% |
|
|
|||||
| Common Stock & APIC | 4.75% | 15.59% | 19.17% | 18.76% | 26.93% |
| Retained Earnings | -9.33% | -24.07% | -28.16% | -32.42% | -39.15% |
| Treasury Stock & Other | -114.55% | -19.18% | -28.17% | 26.25% | -7.01% |
| Total Common Equity | -29.46% | -33.87% | -26.71% | -34.38% | -20.43% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -29.46% | -33.87% | -26.71% | -34.38% | -20.43% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -29.46% | -33.87% | -26.71% | -34.38% | -22.15% |
|
|
|||||